Full Episode
Friday, Sep 5
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

We're not going anywhere.

Stand up for truly independent, trusted news that you can count on!
Donate now
PBS News

Get news alerts from PBS News

Turn on desktop notifications?

pharmaceutical industry

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live

Apr 24

Watch 6:14
How federal case against drug distributor could change opioid fight

Amid the ongoing opioid epidemic, drug manufacturers, doctors and pharmacists have all come under fire. But it's a drug distributor, a company called RDC, at the center of a new federal criminal case that equates its business operations with illegal…

Continue watching

Feb 26

WATCH: Drug companies ‘bear none of the consequences’ of skyrocketing prices, Sen. Wyden says

By Ricardo Alonso-Zaldivar, Matthew Perrone, Associated Press

The hearing marks the first time lawmakers have called top industry executives to account for rising prices that are squeezing Americans.

Continue reading

Jan 14

House Democrats announce they are investigating drug pricing

By Ricardo Alonso-Zaldivar, Associated Press

House Democrats announced a sweeping investigation Monday of the pharmaceutical industry's pricing practices, jockeying for the upper hand with the Trump administration on an issue that concerns Americans across the political spectrum.

Continue reading

Aug 11

Watch 11:08
Do prescription drug middlemen help keep prices high?

By Megan Thompson, Mori Rothman

Americans pay more for prescription drugs than any country in the world, and the pharmaceutical industry earns billions in profits each year. Critics blame pharmacy benefit managers, or PBMs, for a portion of those high costs through their role as…

Continue watching

Jun 30

Justice Department announces crackdown on fraudulent opioid prescriptions

By Lev Facher, STAT

Federal agencies on Thursday announced charges in what Attorney General Jeff Sessions called “the largest health care fraud takedown in American history,” an investigation into over $2 billion in alleged fraud by doctors, pharmacists, and nurses.

Continue reading

May 23

Column: Not sure what to make of Trump’s drug prices plan? Here’s where to start

By Philip Moeller

Rushing to judgment is misguided. There are no quick fixes here, and while the Trump proposals are viewed as fatally flawed by many experts, they also include some worthy ideas.

Continue reading

Jun 07

Nevada bill would require insulin makers to post profits

By Emily Kopp, Kaiser Health News

The cost of insulin medications has steadily risen over the past decade by nearly 300 percent.

Continue reading

Dec 06

Who wins and loses with the 21st Century Cures Act?

By Sheila Kaplan, STAT

More than 1,300 lobbyists roamed the halls of Congress on the 21st Century Cures Act, and disclosure reports show most of them were working for pharmaceutical companies.

Continue reading

Jun 02

Column: Our zeal for antibiotics in agriculture could become an economic nightmare

By Vikram Mansharamani

The superbug is a reminder of the unintended consequences of the modern quest for productivity. Barring a solution, it will take an enormous toll.

Continue reading

Feb 10

Lower drug prices: Does any candidate have an Rx?

By Philip Moeller

The absence of drug-pricing proposals from the GOP contenders illustrates how hard it would be for Sanders or Clinton to get Congressional approval should they win office.

Continue reading

Jump to the First Page Previous Page
1 2 3 4
Next Page Jump to the Last Page

Support Provided By: Learn more

web ad

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Full Episode
Friday, Sep 5
  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You
  • Friends of the News Hour
PBS News

© 1996 - 2025 NewsHour Productions LLC. All Rights Reserved.

PBS is a 501(c)(3) not-for-profit organization.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy
  • Terms of Use

Stay Connected

  • Facebook
  • YouTube
  • Instagram
  • X
  • TikTok
  • Threads
  • RSS

Subscribe to Here's the Deal with Lisa Desjardins

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Support for News Hour Provided By

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Raymond James
  • Viewers Like You